共 105 条
[1]
Cho MS(2017)Differential ratesand clinical significance of periprocedural myocardial infarction after stenting or bypass surgery for multivessel coronary disease according to various definitions JACC Cardiovasc Interv 10 1498-1507
[2]
Ahn JM(2016)Microvascular (Dys) function and clinical outcome in stable coronary disease J Am Coll Cardiol 67 1170-1172
[3]
Lee CH(2003)Novel index for invasively assessing the coronary microcirculation Circulation 107 3129-3132
[4]
Kang DY(2016)Relation between neutrophil-to-lymphocyte ratio and index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention Am J Cardiol 118 1323-1328
[5]
Lee JB(2019)GW29-e0502 Danhong Injection enhances angiogenesis after myocardial infarction by activating MiR-126/ERK/VEGF pathway Biomed Pharmacother 120 109538-681
[6]
Lee PH(2012)2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/Non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): A Report of the American College of Cardiology J Am Coll Cardiol 60 645-223
[7]
De Bruyne B(2019)Periprocedural myocardial infarction in contemporary practice Interventional Cardiol Clin 8 209-565
[8]
Oldroyd KG(2009)Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention J Am Coll Cardiol 54 558-2106
[9]
Pijls NHJ(2005)Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for reduction of myocardial damage during angioplasty) study Circulation 111 2099-1463
[10]
Fearon WF(2006)Safety and efficacy of short-term celecoxib before elective percutaneous coronary intervention for stable angina pectoris Am J Cardiol 98 1461-8